We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+4.74%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$61.7B
AUM Growth
+$546M
(+0.89%)
Cap. Flow
-$4.01B
Cap. Flow
% of AUM
-6.5%
Top 10 Holdings %
Top 10 Hldgs %
23.47%
Holding
1,295
New
145
Increased
379
Reduced
411
Closed
104
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$218M |
| 2 |
Bank of America
BAC
|
+$205M |
| 3 |
Dollar General
DG
|
+$198M |
| 4 |
Union Pacific
UNP
|
+$197M |
| 5 |
Elevance Health
ELV
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$505M |
| 2 |
Rockwell Automation
ROK
|
+$373M |
| 3 |
CHL
China Mobile Limited
CHL
|
+$294M |
| 4 |
eBay
EBAY
|
+$222M |
| 5 |
TSMC
TSM
|
+$220M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.38% |
| 2 | Healthcare | 15.97% |
| 3 | Financials | 13.78% |
| 4 | Industrials | 11.75% |
| 5 | Communication Services | 10.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLLS
626
Cellectis
CLLS
$287M
| $2.38M | ﹤0.01% |
152,558
-23,565
| -13% | -$421K |
|
627
Vale
VALE
$63.8B
| $2.38M | ﹤0.01% |
176,840
+6,087
| +4% | +$78.1K |
|
|
CELG
628
DELISTED
Celgene Corp
CELG
| $2.37M | ﹤0.01% |
+25,647
| New | +$2.44M |
|
629
State Street SPDR S&P 500 ETF Trust
SPY
$784B
| $2.35M | ﹤0.01% |
8,015
+4,335
| +118% | +$1.25M |
|
630
Veeva Systems
VEEV
$32.7B
| $2.32M | ﹤0.01% |
+14,313
| New | +$2.09M |
|
|
CCMP
631
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $2.32M | ﹤0.01% |
21,081
-40,763
| -66% | -$4.61M |
|
632
Dover
DOV
$27.5B
| $2.27M | ﹤0.01% |
22,625
+18,625
| +466% | +$1.79M |
|
633
Extra Space Storage
EXR
$31.3B
| $2.21M | ﹤0.01% |
20,831
-521
| -2% | -$54.7K |
|
634
Dr. Reddy's Laboratories
RDY
$9.85B
| $2.21M | ﹤0.01% |
294,540
-261,890
| -47% | -$2.06M |
|
|
TCO
635
DELISTED
Taubman Centers Inc.
TCO
| $2.17M | ﹤0.01% |
53,170
-118
| -0.2% | -$5.68K |
|
636
Galicia Financial Group
GGAL
$8.29B
| $2.16M | ﹤0.01% |
+60,827
| New | +$1.63M |
|
637
The Mosaic Company
MOS
$7.24B
| $2.16M | ﹤0.01% |
86,197
-28,635
| -25% | -$699K |
|
638
TransUnion
TRU
$15.4B
| $2.11M | ﹤0.01% |
28,700
| – | – |
|
|
HTT
639
High Templar Tech Ltd
HTT
$379M
| $2.1M | ﹤0.01% |
280,118
+279,298
| +34,061% | +$1.92M |
|
640
Fair Isaac
FICO
$26.4B
| $2.04M | ﹤0.01% |
6,514
-8,342
| -56% | -$2.42M |
|
641
Gray Television
GTN
$417M
| $2.04M | ﹤0.01% |
124,476
+78,743
| +172% | +$1.56M |
|
642
Casey's General Stores
CASY
$32.1B
| $2.04M | ﹤0.01% |
+13,047
| New | +$1.78M |
|
643
Amphenol
APH
$197B
| $2.01M | ﹤0.01% |
83,936
+66,228
| +374% | +$1.59M |
|
644
Blackrock
BLK
$170B
| $2.01M | ﹤0.01% |
4,278
+125
| +3% | +$56.5K |
|
|
VG
645
DELISTED
Vonage Holdings Corporation
VG
| $2M | ﹤0.01% |
+176,800
| New | +$1.91M |
|
646
Bruker
BRKR
$9.79B
| $1.99M | ﹤0.01% |
39,757
+759
| +2% | +$32K |
|
647
Chemours
CC
$2.57B
| $1.97M | ﹤0.01% |
82,247
-2,447
| -3% | -$72.1K |
|
648
Turning Point Brands
TPB
$1.47B
| $1.93M | ﹤0.01% |
39,332
| – | – |
|
649
United Airlines
UAL
$40.1B
| $1.92M | ﹤0.01% |
21,938
-31,383
| -59% | -$2.66M |
|
650
Sony
SONY
$134B
| $1.92M | ﹤0.01% |
182,945
+173,565
| +1,850% | +$1.7M |
|
Similar funds
QCM
Lazard Asset Management's Q2 2019 Portfolio in Review
As of Q2 2019, Lazard Asset Management held 1,295 positions worth $61.7B, up 0.89% from $61.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Lazard Asset Management withdrew a net $4.01B in Q2 2019, closing 104 positions and reducing 411 holdings. Its most notable exit was Utah Medical Products, an estimated $13.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lazard Asset Management opened a new position in Sabre worth $132M.
- Lazard Asset Management's largest Q2 2019 buy was Sabre: 5,927,264 shares worth $132M.
- Lazard Asset Management added most to Walt Disney in Q2 2019, an estimated $218M increase.
- Lazard Asset Management's biggest Q2 2019 reduction was Wells Fargo, cutting an estimated $505M.
- Lazard Asset Management fully exited Utah Medical Products in Q2 2019, selling an estimated $13.7M.
- Lazard Asset Management's ten largest holdings make up 23% of its $61.7B portfolio in Q2 2019.
- Lazard Asset Management opened 145 new positions and closed 104 in Q2 2019.
- Lazard Asset Management's portfolio value rose 0.89% quarter-over-quarter to $61.7B.
Based on Lazard Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.